TIS
Click for more information
0.00% 0.0¢ tissue therapies limited

PIP caused a doubling down ripple effect across approvals IMHO,...

  1. Brickwalls
    6,187 Posts.
    lightbulb Created with Sketch. 497
    clock Created with Sketch.
    08/09/14
    21:36
    Post #: 13943140
    PIP caused a doubling down ripple effect across approvals IMHO, particularly in Europe. However, as TIS have stated that "Target for start of sales in the USA with reimbursement, 26 months from start of pivotal trial" and as many other Juristrictions accept CE as FDA there now looks to be little difference between paths.
    TIS Price at posting: 40.0¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Thrilling study results take Orthocell a step closer to FDA clearance
right-arrow Created with Sketch.
NEWS OVD027 intercepts massive sulphide creating continued optimism
right-arrow Created with Sketch.
NEWS Updated resource estimates soar for the Pepper Gold Deposit in Western Australia
right-arrow Created with Sketch.
USQ Expanded deep drilling gold program unveiled for Leonora flagship project
right-arrow Created with Sketch.
NEWS Peppermint looks to elevate AI and data transformation
right-arrow Created with Sketch.
NEWS $6.2 million Government Grant secured by Hazer to progress technology commercialisation
right-arrow Created with Sketch.
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.